Allergan has entered into an agreement to acquire Zeltiq Aesthetics, maker of the CoolSculpting system, for roughly $2.475 billion. The sale is expected to close in the second half of 2017. “The acquisition of Zeltiq is highly complementary and strategic to Allergan. By adding the best-in-class body contouring CoolSculpting System to our best-in-class facial aesthetics, plastic surgery and regenerative...

Articles

Allergan has entered into an agreement to acquire Zeltiq Aesthetics, maker of the...

Hologic—a developer, manufacturer and supplier of diagnostic products, medical imaging...

Image of Ray Canole

Revision Skincare is pleased to announce the appointment of Ray Canole to the position...

A woman with problem skin.

A recent study published in Dermatologic Surgery (February 2017) evaluated...

Products

Professional Peel

The physician-strength ProSystem Retinol Peel from NeoStrata contains 3%...

Cellulite Reducer

The EndyMed Contour handpiece is FDA cleared for temporary reduction in the...

Tinted Sun Protection

EltaMD UV Elements Broad-Spectrum SPF 44 is a 100% physical sunscreen in a...

Easier Aspiration

The Lee Aspirator is a patent-pending safety device that snaps onto cosmetic...

Blogs

Addressing Employee Tardiness
By Paul Edwards, CEO of CEDR HR Solutions There’s nothing more maddening than knowing your patients are due to arrive at your door at any moment, but because one or more of your employees STILL hasn’t shown up for work, you won’t be able to take the patients back right away. Despite the many...
Instagram Stories
By Jasmine Hill, MBA at Aesthetic Influencer Instagram launched their Snapchat-like feature, Instagram Stories this week. The feature lets you share a series of photos or videos (up to 10 seconds) to your followers that will disappear from view in 24 hours. Some aesthetic offices have already...
Allergan To Acquire Zeltiq

Allergan has entered into an agreement to acquire Zeltiq Aesthetics, maker of the CoolSculpting system, for roughly $2.475 billion. The sale is expected to close in the second half of 2017. “The acquisition of Zeltiq is highly complementary and strategic to Allergan. By adding the best-in-class body contouring CoolSculpting System to our best-in-class facial aesthetics, plastic surgery and regenerative medicine offerings we are creating a world-class aesthetics business,” said Brent Saunders, chairman and CEO of Allergan.

Hologic To Acquire Cynosure

Hologic—a developer, manufacturer and supplier of diagnostic products, medical imaging systems and surgical products—and laser manufacturer Cynosure have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, for a total cost of approximately $1.65 billion. The boards of directors of both companies have approved the transaction unanimously.

“Acquiring Cynosure will accelerate our transformation into a higher-growth company by leveraging our core women’s health expertise and OB/GYN channel leadership into an adjacent, cash-pay segment that is expanding at a low double-digit rate,” said Steve MacMillan, Hologic’s chairman, president and CEO. “We had identified medical aesthetics as an attractive and complementary growth opportunity through our strategic planning process, and are pleased to have agreed to acquire Cynosure, the best-in-class company in the space. Together, we can strengthen our shared focus on innovation, market-leading products with demonstrated clinical benefits, and strong customer relationships.”

Canole Joins Revision Skincare

Revision Skincare is pleased to announce the appointment of Ray Canole to the position of chief commercial officer. Canole brings more than 15 years of business development and commercial related experience in dermatology-focused organizations to the position. He formerly worked with Renaissance Pharma and held various leadership positions in business and corporate development at the Perrigo Company. Canole’s background also includes experience as an investment banker at William Blair and Company.

“I’m thrilled to be joining the Revision Skincare team, especially at this point in the company’s evolution,” says Canole. “The company’s rich history, superior product offering, track record of innovation and ownership of the entire supply chain, from R&D to a world-class manufacturing facility located in Dallas, positions us optimally for future growth. As we move into 2017, our team will be focused on adding talent, enhancing our product portfolio and raising brand awareness on a global scale.”

AAD Commends FDA for Indoor Tanning Restrictions

The American Academy of Dermatology (AAD) applauds the U.S. Food and Drug Administration (FDA) for proposing new regulations governing indoor tanning, including an age restriction for minors under the age of 18 as well as a risk-acknowledgement form that all adults must sign before using indoor tanning devices.


According to the AAD, statistics show that millions of people tan indoors annually and the risk of developing melanoma increases by 59% for individuals exposed to UV radiation from indoor tanning—the risk increases with each use. If the FDA’s proposed rule becomes final,... more »

ASDS Honored With 14 MarCom Awards

The American Society for Dermatologic Surgery (ASDS) and American Society for Dermatologic Surgery Association (ASDSA) were recognized with 14 awards—including three Platinums—in the 2015 MarCom Awards.


The MarCom Awards competition is administered and judged by the Association of Marketing and Communication Professionals, selecting winners “whose work serves as a benchmark for the industry.” The 2015 competition received about 6,500 entries representing more than a dozen countries.


The Platinum Award—MarCom’s top honor—was presented to ASDS in three categories: Currents... more »

Cellfina Available in US

Merz Aesthetics has begun commercial shipment of the Cellfina System, indicated for long-term improvement in the appearance of cellulite in the buttocks and thighs, to aesthetic practices in the U.S.


Cellfina combines proprietary technology with minimally invasive subcision to treat the primary structural cause of dimpled cellulite. Results of the procedure last at least two years—in clinical trials, patient satisfaction with their treatment results improved from 94% at one year to 96% at the two-year mark. The most common side effects reported were soreness, tenderness and bruising... more »